Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Guidewire Technique Versus Transpancreatic Precut in Patients With Repetitive Unintentional Cannulation of the Pancreatic Duct.

NCT04503200 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04503200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04503200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Guidewire Technique Versus Transpancreatic Precut in Patients With Repetitive Unintentional Cannulation of the Pancreatic Duct.
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Unknown status
Start date
August 15, 2020
Completion date
August 30, 2022
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common bile duct diseases, double guidewire, endoscopic retrograde cholangiopancreatography, precut, transpancreatic precut